RxDoctor Payments Data

Trisha Shamp

Medical · Minneapolis, MNNPI 1811190226

Payments from drug & device makers

What this record shows

That places this record below the midpoint for medical clinicians in MN, where the typical reported total is $112.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$2,499,278in research payments, 2019–2025

Across 67 payments — averaging $37,303 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$791K
  • Roche Diagnostics Operations, Inc.$595K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$422K
  • Lexicon Pharmaceuticals, Inc.$245K
  • Sanofi$192K
  • Astrazeneca UK Limited$176K
  • plus $78K from 3 others

How this compares

$0 in reported general payments places this provider in the 0th percentile of 202 medical providers in Minnesota.

See all medical providers in Minnesota →

Other medical in Minneapolis

See the full list for Minnesota →

Where these figures come from

Is this you, or does something look wrong? →